title: Long-term maintenance of improvements achieved with (abortive) pharmacological and nonpharmacological treatments for migraine: preliminary findings.
abstract: This report presents the first prospective comparison of the long-term maintenance of reductions in recurrent migraine headaches achieved with (abortive) pharmacological and nonpharmacological (combined relaxation training and thermal biofeedback training) treatments. Nineteen of 21 (90%) successfully treated patients (50% or greater reduction in headache activity) were contacted for follow-up evaluation 3 years later. Migraine sufferers who had been treated with ergotamine were less likely to still be relying on the treatment they had received and more likely to have additional medical treatment for their headaches and to be using prophylactic or narcotic medication than were migraine sufferers who had been treated with relaxation/biofeedback training. However, daily headache recordings revealed that patients in both treatment groups continued to show lower headache activity at 3-year follow-up than prior to treatment. Although preliminary, these findings raise the possibility that improvements achieved with nonpharmacological treatment are more likely to be maintained without additional treatment than are similar improvements achieved with abortive pharmacological treatment.
authors.affiliation: Department of Psychology, Ohio University, Athens 45701-2979.
authors.forename: K A
authors.initials: KA
authors.lastname: Holroyd
authors.forename: J F
authors.initials: JF
authors.lastname: Holm
authors.forename: D B
authors.initials: DB
authors.lastname: Penzien
authors.forename: G E
authors.initials: GE
authors.lastname: Cordingley
authors.forename: K G
authors.initials: KG
authors.lastname: Hursey
authors.forename: N J
authors.initials: NJ
authors.lastname: Martin
authors.forename: A
authors.initials: A
authors.lastname: Theofanous
mesh_terms: D000328:Adult; D001676:Biofeedback, Psychology; D004878:Ergotamine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy / Q000628:therapy*; D012008:Recurrence; D012064:Relaxation Therapy; D011795:Surveys and Questionnaires
chemical_list: D004878:Ergotamine